Articles Patents
Biden Should Respect Vaccine Makers’ Patent Rights
Market Institute President Charles Sauer has a new piece in RealClear Policy on patent rights. The White House recently issued a patent waiver for Covid-19 vaccines. Here’s an excerpt of Sauer’s article: “President Biden recently made what the Wall Street Journal referred to as the worst single Presidential decision since Nixon’s Read more…
Articles Patents
Trump’s presidency has had some redeeming qualities: Innovation was protected
Market Institute President Charles Sauer has a new article up at the Washington Examiner on how the United States Patent and Trademark Office has empowered innovation the last 4 years. President Trump’s legacy will be something that is debated for years to come, but his administration did have some redeeming Read more…
Articles
Trump enabled the vaccine moonshot, but his drug price rule threatens future innovation
The Market Institute President Charles Sauer has a new piece in the Washington Examiner looking at the White House’s newest proposed regulation on importing foreign prices controls for prescription drugs. Here is an excerpt: “On July 20, 1969, the United States landed on the moon. In November, a couple of Read more…
Articles
Republicans Push for Socialist Price Controls in Coronavirus Bill
The Market Institute’s Charles Sauer is out with a new Op-ed in the Washington Examiner looking at legislation on “Surprise Billing.” In the midst of intense negotiations on a phase 4 coronavirus relief bill, a debate is brewing over the inclusion of a ‘fix’ to the issue of surprise billing. Read more…